| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700796 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
Compared to FLOT-chemotherapy, neoadjuvant chemoradiotherapy with the CROSS-protocol in locally advanced adenocarcinoma AEG types I and II resulted in better response by the primary tumour and less lymph node metastasis but without superior survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Favi, E. Bollschweiler, F. Berlth, P. Plum, D.A. Hescheler, H. Alakus, R. Semrau, E. Celik, S.P. Mönig, U. Drebber, A.H. Hölscher,